Pathstone Holdings’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $341K | Buy |
3,262
+10
| +0.3% | +$1.04K | ﹤0.01% | 1873 |
|
|
2025
Q1 | $379K | Sell |
3,252
-254
| -7% | -$29.6K | ﹤0.01% | 1838 |
|
|
2024
Q4 | $297K | Sell |
3,506
-337
| -9% | -$28.5K | ﹤0.01% | 1975 |
|
|
2024
Q3 | $345K | Buy |
3,843
+76
| +2% | +$6.83K | ﹤0.01% | 1904 |
|
|
2024
Q2 | $303K | Sell |
3,767
-54
| -1% | -$4.35K | ﹤0.01% | 1929 |
|
|
2024
Q1 | $305K | Buy |
3,821
+172
| +5% | +$13.7K | ﹤0.01% | 1935 |
|
|
2023
Q4 | $290K | Buy |
+3,649
| New | +$290K | ﹤0.01% | 1843 |
|